Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness

August 12, 2016 updated by: Gülbahar Ustaoğlu, Karadeniz Technical University

Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness at Free Gingival Graft Donor Sites: A Randomised Controlled Clinical Study

Objective: The aim of this study was to determine the effects of Low Level Laser Therapy (LLLT) on wound healing at Free Gingival Graft donor sites (FGGDS).

Materials and Methods: Forty patients requiring FGG were selected for this randomized controlled double blinded prospective clinical trial. The FGGDS were treated with LLLT and compared with an untreated control group. The Wound Healing Index (WHI), tissue consistency, colour match (CM), and H2O2 bubbling test for the evaluation of complete wound epithelialization (CWE) were recorded at the 3rd, 7th, 14th and 21st days. The pain-burning level, number of analgesics, and bleeding were recorded for 7 days. Donor area soft tissue thickness (TT) was measured at baseline and at the 1st month.

Study Overview

Status

Completed

Conditions

Detailed Description

Subjects and Study Design This single center, randomized, double blinded, prospective and controlled clinical study was performed to evaluate the healing time, wound epithelialization and post-operative morbidity produced after harvesting FGG from the palate. The wounds were treated with one of the following methods: sterile wet gauze pressure (control) or LLLT (test).

The patients were randomly assigned to one of the groups by the periodontists with the toss of a coin.

Forty patients requiring FGG were selected, and verbal and written informed consent were obtained.

To minimize the differences related to the surgical technique, all surgical procedures were carried out by one experienced clinician.

Pre-Surgical Treatments All selected patients underwent a professional periodontal prophylaxis phase, and all patients were given proper oral hygiene instructions. Patients who had a full mouth plaque score (FMPS)˂20% and a full mouth bleeding score (FMBS)˂20% were included in the study. The patients were assigned to the control or test groups by the coin toss method.

Surgical Procedure After local anaesthesia, the free gingival graft was harvested as follows: the donor site extended from the distal line angle of the canine to the mesial line angle of the maxillary first molar by conventional scalpel. An approximately 1.5 mm split-thickness and rectangular-shaped (7x12 mm) gingival graft was obtained. The free gingival graft was sutured to the prepared recipient bed using size 5-0 resorbable sutures.

Test Group - LLLT The Ga-Al-As laser was used for LLLT at a wavelength of 940 nm. The wounds of each experimental group received laser stimulation at doses of 8.6 J/cm2, very closed the described dose (10 J/cm2) in the literature. The power output was maintained at a constant 3 W in the continuous-wave (cw) mode; the pulse interval size was 0.10 ms, and the pulse length was 0.05 ms. Laser energy was applied via a 400-µm optical fibre with a Whitening and Pain Relief Handpiece® . The handpiece was positioned at a distance of approximately 1 mm proximal to the wound area perpendicularly at a non-contact mode. The spot area of handpiece involved all the wound area . The application area was actually similar with the probe spot area (2.8 cm2). The wound area was 7x12=0.84 cm2. So the spot area of the probe was wider than the wound area and included all the wound area. For this reason, we did not need to move the handpiece, only kept constant. All surfaces of the wound were irradiated leading to total dosage of 8.6 J/cm2 and the irradiation time was 8 s. The energy at the wound area was 7.2 J (0.84 cm2 x 8.6 J/cm2 =7.2 J). The specified laser dose was initiated after surgery and was repeated on the 3rd, 5th, and 7th days after operation. The cumulative dose was 34.4 J/cm2 at total.

Control Group - LLLT Sham Sterile wet gauze was pressed to the FGG donor site for 5 min in the control group. The LLLT was performed in a same manner with test group. However, no irradiation was occurred because of not pushing the start button.

Post operative care A non-eugenol pack was placed over the sutured FGG (Coe-Pak™ Periodontal Dressing, GC America Inc., IL, USA). An acrylic stent was prepared to protect the palatal donor site and placed after surgery and recommended to patients to wear for 7 days. Patients were prescribed 500 mg of paracetamol (if needed) and a 0.12% chlorhexidine oral rinse twice a day for 2 weeks. The patients were advised to report any adverse outcomes and were recalled at 3rd, 7th, 14th, 21st and 30th day (the 5th day for the LLT group). The sutures were removed after 2 weeks.

Evaluated Parameters All evaluations were acquired by one periodontist who was blinded to the treatment assignment. The following parameters were recorded: H2O2 bubbling test for screening complete epithelialization, the Landry Wound Healing Index (WHI), pain and burning sensations by a VAS score, bleeding (yes/no), palatal tissue consistency, colour match, tissue thickness, and the number of analgesics.

Intra-Surgical Measurements of Soft Tissue Thickness The thickness of the palatal soft tissue in the harvesting area was measured after local anaesthesia. The measurement was made approximately 5 mm apical to the gingival margin of the first premolar by means of a #20 endodontic reamer with a silicon stopper. The thickness of the palatinae was measured in the test and control groups. The penetration depth was measured with a digital caliper. The dimensions of the graft were standardized by a sterile aluminium foil template that was 7x12 mm in dimension.

Subjective Assessments During the 7 days after the FGG procedure, the patients were asked to keep a diary of pain and burning sensations using a Visual Analogue Scale (VAS) to evaluate the intensity of the given event. The VAS score for pain ranged from 0 (no pain) to 100 (severe pain), represented by a continuous line of 10 cm length; while the burning sensation was scored as follows: 0 (absent) to 100 (severe burning). Additionally, the patients were asked to report their postoperative bleeding for 7 days as "Bleeding present (+)" or "Bleeding absent (-)".

Palatal Tissue Consistency The consistency of the palatal mucosa was assessed on the 3rd, 7th, 14th and 21st days by palpation with a blunt instrument and was scored as soft or firm by a clinician who was blind to the treatment assignment.

Colour match On the 3rd, 7th, 14th and 21st days, the colour of the palatal mucosa was assessed by comparing it to that of the adjacent and opposite side using the objective VAS (VAS score 0-100) represented by a continuous line of 10 cm length, by a clinician blinded to the treatment group assignment. A score of 0 indicated no colour match, and a score of 100 indicated a very good colour match with the adjacent tissues.

Wound Epithelialization CWE (complete Wound Epithelialization) was evaluated clinically by the peroxide bubbling test . This was the primary outcome of this study. This test is based on the principle that if the epithelium is discontinuous, then H2O2 diffuses into the connective tissue, and the enzyme catalase acts on H2O2 to release water and oxygen, which is clinically observed as the production of bubbles on the wound. The area to be evaluated was dried, and 3% H2O2 was sprinkled on the wound with a syringe, followed by a period of waiting (approximately 10 seconds) for the appearance of bubbles, which suggest that the surgical site was not completely epithelialized.

Landry Wound Healing Index (WHI) The palatal wounds were scored using the Landy Wound Healing Index on the 3rd, 7th, 14th and 21st days post operatively. This index evaluated the wounds based on the following criteria: tissue colour, response to palpation, incision margins and suppuration. The scores range from 1-5 and correspond to very bad to excellent healing.

The number of analgesics Patients were asked to record the number of analgesics taken for pain relief during the first 7 post-operative days.

Statistical Analysis The homogeneity of the data was tested by the Shapiro Wilk test. Non-parametric tests were used. SPSS v.17.0 (SPSS Inc., Chicago, Illinois USA) was used for the analysis. The Mann-Whitney U test was used to analyze intergroup differences. Time dependent alterations were analyzed by the Wilcoxon test. The Binary Logistic Regression Analysis was performed to analyze the factors that affect epithelialization. Significance level was p<0.05.

Power Calculation The primary outcomeof this study were the H2O2 test results. The power analysis was performed with ttp://www.openepi.com/Menu/OE_Menu.htm. The power of this study was calculated as 98.86%.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The absence of systemic factors (no systemic disease, no coagulation disorders, no medications affecting periodontal status, and no pregnancy or lactation)
  2. No smoking
  3. Patients who had a full mouth plaque score (FMPS)˂20% and a full mouth bleeding score (FMBS)˂20%
  4. No periodontal surgery on the experimental site
  5. No nauseal reflection

Exclusion Criteria:

  1. Smoking
  2. The presence of systemic disease
  3. Bad oral hygiene-
  4. The history of periodontal surgery on the experimental site
  5. Nauseal reflection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test Group
In Test group, the free gingival graft donor sites of each experimental group received low-level laser therapy by Ezlase; Biolase® at doses of 8.6 J/cm2.
comparision of the effects of low-level-laser therapy on wound healing of palatal donor site
Sham Comparator: Control Group
In Control Group, the low-level laser therapy by Ezlase; Biolase® was performedin a same manner with test group at free gingival graft donor sites. However, no irradiation was occurred because of not pushing the start button.
comparision of the effects of low-level-laser therapy on wound healing of palatal donor site

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete Wound Epithelization
Time Frame: 14th. day after surgery
The 14th day H2O2 Bubbling test results that show Complete Wound Epithelization
14th. day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palatal Tissue Thickness
Time Frame: at baseline and at the 1st month
The tissue thickness alterations (mm.) that was measured by a endodontic reamer and digital caliper was the secondary outcome
at baseline and at the 1st month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

August 1, 2016

First Submitted That Met QC Criteria

August 12, 2016

First Posted (Estimate)

August 15, 2016

Study Record Updates

Last Update Posted (Estimate)

August 15, 2016

Last Update Submitted That Met QC Criteria

August 12, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24237859-545

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds

Clinical Trials on Low-Level Laser Therapy by Ezlase; Biolase®

Subscribe